FDA issued a Warning Letter to Kings Park Slope Inc on 3/27/2015 for a previous inspection.
483 Kings Park Slope Jun 2016

483 Kings Park Slope Jun 2016

$119 - Not in Stock

FDA investigators audited the Kings Park Slope - Brooklyn, NY, United States facility and issued inspectional observations (via FDA 483) on 06 Jun 2016.

Product details

  • Category: Human Drugs
  • Inspection end: 06 Jun 2016
  • Location: Brooklyn, United States
  • FEI: 3007174596
Order